Together with Investors and Biotech companies we develop scientific innovations into medicines for tomorrow. As specialists in early drug development, we provide Opportunities/Risk Assessments for critical Go/No Go decisions and Leading-Edge Development Advice for accelerated strategies, saving time and money. With our broad expertise across all areas of drug development we can quickly assess the potential of an opportunity and spot the areas that could become show-stoppers. Our fast track early development strategies integrate biomarkers and contemporary data analysis (computer models) to drive scientifically-sound decision making and increase the chances of development success.